摘要:
The present invention relates to a process for the preparation of Lenvatinib of formula (I) from 4-amino-3-chloro-phenol and 4-chloro-7-methoxyquinoline-6-carboxamide.
摘要:
The present invention refers to an amorphous form of a thiocolchicine derivative, IDN 5404, to a process for producing it and to pharmaceutical compositions thereof. The amorphous form is characterised by the XRPD pattern, DSC profile and/or TG/DTA profile.
摘要:
The invention discloses 2-((2 R ,4 R )-4-(4-(benzyloxy)- 4-methylpent-2-yn-1-yl)-2-(tert-butyl) -5-oxo-1,3-dioxolan-4-yl)acetic acid of formula (XIX), a process for its preparation and processes for its conversion into enantiomerically pure ( R )-2-(2-methoxy-2-oxoethyl)-6,6-dimethyltetrahydro-2 H- pyran-2-carboxylic acid of formula (I), a molecule useful for the synthesis of Homoharringtonine.
摘要:
The present invention refers to an amorphous form of a thiocolchicine derivative, IDN 5404, to a process for producing it and to pharmaceutical compositions thereof. The amorphous form is characterised by the XRPD pattern, DSC profile and/or TG/DTA profile.
摘要:
The invention relates to a solid dispersion comprising Coenzyme Q 10 and a phospholipid, in the presence of a cellulosic derivative and/or a polymeric material belonging to the groups of oligo and polysaccharides, linear and/or cross-linked polymers of N-vinyl-2-pyrrolidone, linear polymers of vinyl alcohol, polymers of vinyl acetate, co-polymers of methacrylic acid and ethyl acrylate, co-polymers of ethylene oxide and propylene oxide, polyethylene glycols.